Ascendis Pharma A/S (ASND) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Ascendis Pharma A/S's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-50.13
Earnings Deficit
P/B Ratio
-67.58
Equity Deficit
Earnings Yield
-1.99%
Yield Gap
Profitability Health
2025Return on Equity
134.58%
Strong
WeakModerateStrong
Operating Margin
-18.92%
Weak
WeakModerateStrong
Net Profit Margin
-31.67%
Weak
WeakModerateStrong
Growth Indicators
2025Revenue Growth
90.22%
Strong
WeakModerateStrong
Net Income Growth
42.07%
Strong
WeakModerateStrong
EPS Growth
44.56%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
1.04
Moderate
WeakModerateStrong
Quick Ratio
0.76
Weak
WeakModerateStrong
Asset Turnover
0.53x
Moderate
WeakModerateStrong
Inventory Turnover
0.34x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
0.40%
Weak
WeakModerateStrong
EV / Free Cash Flow
258.03x
Weak
WeakModerateStrong
Net Debt / EBITDA
-2.33x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.561
Strong
WeakModerateStrong
Return on Invested Capital
-18.19%
Weak
WeakModerateStrong
Cash Conversion Cycle
828.84 days
Weak
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for ASND.
View Financial Statements